<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="editorial" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phgenomics</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакогенетика и фармакогеномика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacogenetics and Pharmacogenomics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2588-0527</issn><issn pub-type="epub">2686-8849</issn><publisher><publisher-name>LLC "Izdatelstvo OKI"</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">phgenomics-334</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОТ ГЛАВНОГО РЕДАКТОРА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>FROM EDITOR</subject></subj-group></article-categories><title-group><article-title>От главного редактора</article-title><trans-title-group xml:lang="en"><trans-title>From Editor-in-Chief</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сычев</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sychev</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сычев Дмитрий Алексеевич, д. м. н., профессор, академик РАН, главный редактор журнала «Фармакогенетика и Фармакогеномика».</p></bio><email xlink:type="simple">dimasychev@mail.ru</email></contrib></contrib-group><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>19</day><month>01</month><year>2026</year></pub-date><volume>0</volume><issue>3</issue><fpage>3</fpage><lpage>3</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сычев Д.А., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Сычев Д.А.</copyright-holder><copyright-holder xml:lang="en">Sychev D.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacogenetics-pharmacogenomics.ru/jour/article/view/334">https://www.pharmacogenetics-pharmacogenomics.ru/jour/article/view/334</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sanghvi MM, Young WJ, Naderi H, et al. Using genomics to develop personalized cardiovascular treatments. Arterioscler Thromb Vasc Biol. 2025 Jun;45(6):866-881. doi: 10.1161/ATVBAHA.125.319221.</mixed-citation><mixed-citation xml:lang="en">Sanghvi MM, Young WJ, Naderi H, et al. Using genomics to develop personalized cardiovascular treatments. Arterioscler Thromb Vasc Biol. 2025 Jun;45(6):866-881. doi: 10.1161/ATVBAHA.125.319221.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
